---
stable_id: R-HSA-2029992
display_name: Tyrosine kinase inhibitors bind to overexpressed FGFR2 variants
species: Homo sapiens
summary: Amplified FGFR2 has been shown to be a potential target for a number of ATP-competitive
  inhibitors, some of which are currently in clinical trials for therapeutic use (Takeda,
  2007; Turner, 2010; http://clinicaltrials.gov).
---

# Tyrosine kinase inhibitors bind to overexpressed FGFR2 variants
**Reactome ID:** [R-HSA-2029992](https://reactome.org/content/detail/R-HSA-2029992)
**Species:** Homo sapiens

## Summary

Amplified FGFR2 has been shown to be a potential target for a number of ATP-competitive inhibitors, some of which are currently in clinical trials for therapeutic use (Takeda, 2007; Turner, 2010; http://clinicaltrials.gov).
